Trial intelligence / Profile preview

TwinMet: Metformin for Preterm Birth Prevention in Twin Pregnancy

NCT05412056Phase 3Unknown

Sponsor
The University of Hong Kong
Start
Jun 2022
Primary completion
Jun 2025
Modality
Small Molecules
01

Overview

A Phase 3 trial of liquid metformin (Aspargo Labs) in preterm birth, sponsored by The University of Hong Kong. Status: unknown.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

preterm birth

Beyond the preview

Go deeper on NCT05412056.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05412056.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call